Search research articles
Contact Us
Filters
Showing results (151-160 of 253) with videos related to
Page
of 26
Sort By:
Journal of the National Cancer Institute
|
September 23, 2024
Disparities in the utilization of magnetic resonance imaging for prostate cancer detection: a population-based study
Christiane J El Khoury, Stephen J Freedland, Krupa Gandhi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 2018
Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling
Yuan-Li Tsai, Dat P Ha, He Zhao, et al.
Genes, Chromosomes & Cancer
|
May 1, 2020
Novel CTNND2-TERT fusion in a spindle cell liposarcoma
Michael Occidental, Guomiao Shen, Xiaojun Feng, et al.
Annals of Plastic Surgery
|
May 19, 2011
The impact of reduction mammaplasty on breast sensation: an analysis of multiple surgical techniques
Marcia E Spear, Lillian B Nanney, Sharon Phillips, et al.
BMC Cancer
|
June 3, 2021
Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
Weelic Chong, Zhenchao Zhang, Rui Luo, et al.
Leukemia & Lymphoma
|
April 7, 2010
Large granular lymphocyte leukemia: natural history and response to treatment
Anne F Fortune, Kevin Kelly, Jeremy Sargent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2022
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Zachary Quinn, Benjamin Leiby, Guru Sonpavde, et al.
BJU International
|
February 21, 2014
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer
Jonathan L Silberstein, Stephen A Poon, Daniel D Sjoberg, et al.
Clinical Genitourinary Cancer
|
October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004
Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer
William Kevin Kelly, Andrew X Zhu, Howard Scher, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 253) with videos related to
Sort By:
Page
of 26
Journal of the National Cancer Institute
|
September 23, 2024
Disparities in the utilization of magnetic resonance imaging for prostate cancer detection: a population-based study
Christiane J El Khoury, Stephen J Freedland, Krupa Gandhi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 15, 2018
Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling
Yuan-Li Tsai, Dat P Ha, He Zhao, et al.
Genes, Chromosomes & Cancer
|
May 1, 2020
Novel CTNND2-TERT fusion in a spindle cell liposarcoma
Michael Occidental, Guomiao Shen, Xiaojun Feng, et al.
Annals of Plastic Surgery
|
May 19, 2011
The impact of reduction mammaplasty on breast sensation: an analysis of multiple surgical techniques
Marcia E Spear, Lillian B Nanney, Sharon Phillips, et al.
BMC Cancer
|
June 3, 2021
Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
Weelic Chong, Zhenchao Zhang, Rui Luo, et al.
Leukemia & Lymphoma
|
April 7, 2010
Large granular lymphocyte leukemia: natural history and response to treatment
Anne F Fortune, Kevin Kelly, Jeremy Sargent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2022
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Zachary Quinn, Benjamin Leiby, Guru Sonpavde, et al.
BJU International
|
February 21, 2014
Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer
Jonathan L Silberstein, Stephen A Poon, Daniel D Sjoberg, et al.
Clinical Genitourinary Cancer
|
October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004
Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer
William Kevin Kelly, Andrew X Zhu, Howard Scher, et al.
Page
of 26